Tasmania pilot to commence 1st March
February 22, 2024
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened
The introduction of electronic prescriptions has improved patient accessibility to medication and reduced the administrative burden on pharmacies related to faxed or emailed prescriptions. Most
Psychostimulant changes The PDL Professional Officers would like to bring to the attention of NSW pharmacists some recent regulatory changes regarding the requirements to prescribe
With the availability of the latest Pfizer (COMIRNATY®) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject
Every year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive
Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve